Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332

Scandinavian Journal of Immunology

Volumn 54, Issue 1-2, 2001, Pages 117-124

  Andersson, C ^a   Vasconcelos, N M ^b   Sievertzon, M ^a   Haddad, D ^b   Liljeqvist, S ^c   Berglund, P ^c   Liljestrom P ^c,d   Ahlborg, N ^b   Stahl S ^a   Berzins, K ^b  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DNA; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; RNA; RNA DIRECTED RNA POLYMERASE;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC CODE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PLASMID; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROMOTER REGION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; FEMALE; GENETIC VECTORS; IMMUNOGLOBULIN G; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMIDS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RNA, VIRAL; SEMLIKI FOREST VIRUS; VACCINATION; VACCINES, DNA;

EID: 0034958045     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00951.x     Document Type: Article

References (42)

1. DNA and RNA-based vaccines: Principles, progress and prospects
2. DNA vaccines: A review
3. Self-replicating Semliki Forest virus RNA as recombinant vaccine
4. Enhancing immune responses using suicidal DNA vaccines
5. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon
6. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
7. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
8. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles
9. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
10. The malaria antigens
11. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
12. Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum
13. DNA immunization with Plasmodium falciparum serine repeat antigen: Regulation of humoral response by coinoculation of cytokine expression plasmid
14. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime protein boost immunization protocol
15. Comparative study of DNA-based immunization vectors: Effect of secretion signals on the antibody responses in mice
16. Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence
17. Biology of giant proteins of Plasmodium: Resolution on polyacrylamide-agarose composite gels
18. Pf11-1 and Pf332: Two giant proteins synthesized in erythrocytes infected with Plasmodium falciparum
19. Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332
20. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence
21. Inhibition of in vitro growth of Plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332
22. Plasmodium falciparum: Differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA
23. The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes
24. pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts
25. k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332
26. Mammalian cell production and recovery of an RSV vaccine candidate using a target protein specific affinity column
27. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
28. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers
29. Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
30. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
31. Truncated fragments in polymerase chain reaction-based DNA sequencing
32. Two-helper RNA system for production of recombinant Semliki Forest virus particles
33. Semliki Forest virus expression system: Production of conditionally infectious recombinant particles
34. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
35. Plasmodium falciparum: The Pf332 antigen is secreted from the parasite by a Brefeldin A-dependent pathway and is translocated to the erythrocyte membrane via the Maurer's clefts
36. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early stages of Plasmodium falciparum
37. Overcoming codon bias: A method for high-level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli
38. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity
39. Polynucleotide vaccines in animals: Enhancing and modulating responses
40. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA
41. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
42. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine